| Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
| 1 | An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer (CheckMate 577) | Activ, inca nu se recruteaza | SC Oncopremium Team SRL, Baia Mare, Romania, 430295Fundeni Clinical Institute, Gastroenterology and Hepatology Clinic, Bucharest, Romania, 022328Focus Lab Plus SRL, Bucuresti, Romania, 021389Bendis Clinic Srl, Cluj-napoca, Romania, 400352Sf. Nectarie Oncology Center, Craiova, Romania, 200347S.C. Radiotherapy Center Cluj S.R.L., Floresti, Romania, 407280 |
| 2 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin (CheckMate 648) | Activ, inca nu se recruteaza | Focus Lab Plus SRL, Bucuresti, Romania, 021389CF Clinical Hospital Cluj-Napoca, Cluj-Napoca, Romania, 400015Sf. Nectarie Oncology Center, Craiova, Romania, 200347County Emergency Hospital Suceava, Suceava, Romania, 720237 |
| 3 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | Activ, inca nu se recruteaza | S C Pelican Impex SRL ( Site 2403), Oradea, Bihor, Romania, 410469S.C. Radiotherapy Center Cluj S.R.L ( Site 2407), Comuna Floresti, Cluj, Romania, 407280S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2404), Craiova, Dolj, Romania, 200347S.C.Focus Lab Plus S.R.L ( Site 2401), Bucuresti, Sector 2, Romania, 021389S C Oncocenter Oncologie Medicala S R L ( Site 2405), Timisoara, Timis, Romania, 300166S.C.Gral Medical S.R.L ( Site 2406), Bucuresti, Romania, 031422Spitalul Clinic Judetean De Urgenta Constanta ( Site 2402), Constanta, Romania, 900591 |
| 4 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | In curs de recrutare | Institutul Oncologic „Prof.Dr.I.Chiricuta” Cluj Napoca, Cluj-Napoca, Cluj, Romania, 400015Radiotherapy Center Cluj, Floreşti, Cluj, Romania, 407280Centrul de Oncologie Sf. Nectarie, Craiova, Dolj, Romania, 200347Institutul Clinic Fundeni, Bucuresti, Romania, 022328Spitalul Clinic Coltea, Bucuresti, Romania, 030171Medisprof, Cluj-Napoca, Romania, 400641Centrul de Oncologie Euroclinic, Iaşi, Romania, 700106 |
| 5 | Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) | In curs de recrutare | S.C. Radiotherapy Center Cluj S.R.L ( Site 0391) Recruiting Cluj-Napoca, Cluj, Romania, 407280 Contact: Study Coordinator +40742206212 S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0394) Recruiting Craiova, Dolj, Romania, 200347 Contact: Study Coordinator +40722161545 Centrul Medical Topmed ( Site 0398) Recruiting Targu-Mures, Mures, Romania, 540156 Contact: Study Coordinator +40740277907 |
(Visited 30 times, 1 visits today)